This research has the long-range goal of understanding the relationships and interactions of circulating blood platelets in the process of blood coagulation and in the cellular responses of inflammation, repair, and atherosclerosis. During coagulation, platelets release the platelet derived growth factor (PDGF), the principal mitogenic protein in serum for cells of mesenchymal origin. Our research focuses on the biochemistry/mechanism of action of this protein. Because malignant cells respond differently to PDGF than do normal cells, our research also has the goal of understanding further the differences in the cellular responsiveness of normal and malignant cells in culture to PDGF. Our laboratory has purified PDGF to apparent homogeneity, studied in detail the binding of PDGF to surface receptors on Swiss mouse 3T3 cells, and described different responses of cultured cells to this potent mitogen. The present proposal builds upon previous work and is directed to the cell surface receptor for PDGF. We plan to further characterize the 3T3 cell membrane protein stimulated in tyrosine phosphorylation by PDGF (thought to be the PDGF receptor protein) by peptide mapping, to further identify the cell surface receptor by crosslinking the receptor protein to 125I-PDGF, to solubilize the PDGF receptor protein from 3T3 cell membranes, to purify the PDGF receptor protein to apparent homogeneity by affinity chromatography, to characterize the purified receptor protein by physical and chemical criteria, to characterize the anticipated associated receptor protein kinase activity by kinetic criteria and by identifying protein substrates for receptor kinase activity, to obtain monoclonal antibodies to the PDGF receptor protein, and to purify and characterize the PDGF receptor protein from other cell surfaces. These investigations will provide basic information on receptor function, on the regulation of normal cell growth, and on differences in cellular responsiveness of normal and malignant cells to mitogenic proteins. It is hoped that this information will provide further understanding of the processes of inflamation, repair, and atherosclerosis, and new insight into the understanding of how normal cells differ from the malignant cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL031102-05
Application #
3342112
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1983-07-01
Project End
1988-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Herradon, Gonzalo; Ezquerra, Laura; Nguyen, Trang et al. (2005) Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family. Biochem Biophys Res Commun 333:714-21
Pariser, Harold; Ezquerra, Laura; Herradon, Gonzalo et al. (2005) Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem Biophys Res Commun 332:664-9
Liu, J J; Wang, Z Y; Deuel, T F et al. (1999) Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor. Biochem Biophys Res Commun 254:197-9
Zhang, N; Yeh, H J; Zhong, R et al. (1999) A dominant-negative pleiotrophin mutant introduced by homologous recombination leads to germ-cell apoptosis in male mice. Proc Natl Acad Sci U S A 96:6734-8
Silos-Santiago, I; Yeh, H J; Gurrieri, M A et al. (1996) Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity. J Neurobiol 31:283-96
Wang, Z Y; Qiu, Q Q; Gurrieri, M et al. (1995) WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 10:1243-7
Kim, H R; Upadhyay, S; Li, G et al. (1995) Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci U S A 92:9500-4
Wang, Z Y; Qiu, Q Q; Huang, J et al. (1995) Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415-22
Kawahara, R S; Deng, Z W; Denkinger, D J et al. (1994) Role of serine/threonine protein kinases in the induction of JE, a platelet-derived growth factor inducible gene. Biochem Biophys Res Commun 203:1815-20
Deng, Z W; Denkinger, D J; Peterson, K E et al. (1994) Glucocorticoids negatively regulate the transcription of KC, the mouse homolog of MGSA/GRO. Biochem Biophys Res Commun 203:1809-14

Showing the most recent 10 out of 54 publications